All Stories

  1. Ranked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data
  2. Impact of Experimental Bias on Compositional Analysis of Microbiome Data
  3. Integrative analysis of microbial 16S gene and shotgun metagenomic sequencing data improves statistical efficiency
  4. What Can We Learn about the Bias of Microbiome Studies from Analyzing Data from Mock Communities?
  5. Testing microbiome associations with survival times at both the community and individual taxon levels
  6. LOCOM: A logistic regression model for testing differential abundance in compositional microbiome data with false discovery rate control
  7. Associations between microbial communities and key chemical constituents in U.S. domestic moist snuff
  8. Efficient estimation of indirect effects in case‐control studies using a unified likelihood framework
  9. LOCOM: A logistic regression model for testing differential abundance in compositional microbiome data with false discovery rate control
  10. A rarefaction-based extension of the LDM for testing presence–absence associations in the microbiome
  11. Multisample adjusted U-statistics that account for confounding covariates
  12. PhredEM: a phred-score-informed genotype-calling approach for next-generation sequencing studies
  13. Restoring the Duality between Principal Components of a Distance Matrix and Linear Combinations of Predictors, with Application to Studies of the Microbiome
  14. Testing Rare-Variant Association without Calling Genotypes Allows for Systematic Differences in Sequencing between Cases and Controls
  15. PhredEM: A Phred-Score-Informed Genotype-Calling Approach for Next-Generation Sequencing Studies
  16. Utilizing Population Controls in Rare-Variant Case-Parent Association Tests
  17. Robust Regression Analysis of Copy Number Variation Data based on a Univariate Score
  18. Effects of maternal smokeless tobacco use on selected pregnancy outcomes in Alaska Native women: a case–control study
  19. Risk Assessment and Evaluation of Predictions
  20. A Permutation Procedure to Correct for Confounders in Case-Control Studies, Including Tests of Rare Variation
  21. Stratification-Score Matching Improves Correction for Confounding by Population Stratification in Case-Control Association Studies
  22. Age-associated DNA methylation in pediatric populations
  23. California Very Preterm Birth Study: design and characteristics of the population- and biospecimen bank-based nested case-control study
  24. Maternal smokeless tobacco use in Alaska Native women and singleton infant birth size
  25. Control for Confounding in Case-Control Studies Using the Stratification Score, a Retrospective Balancing Score
  26. A weighted accumulation test for associating rare genetic variation with quantitative phenotypes
  27. Inverse Probability of Censoring Weighted U-statistics for Right-Censored Data with an Application to Testing Hypotheses
  28. Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
  29. Microdeletions of 3q29 Confer High Risk for Schizophrenia
  30. Late Preterm Birth and Risk of Developing Asthma
  31. Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
  32. Score-based adjustment for confounding by population stratification in genetic association studies
  33. Fast and Robust Association Tests for Untyped SNPs in Case-Control Studies
  34. SNPs in CAST are associated with Parkinson disease: A confirmation study
  35. A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease
  36. A Regression-based Association Test for Case-control Studies that Uses Inferred Ancestral Haplotype Similarity
  37. Effect of population stratification on the identification of significant single-nucleotide polymorphisms in genome-wide association studies
  38. Genome-wide association analysis of rheumatoid arthritis data via haplotype sharing
  39. MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasiveStreptococcus pyogenesisolates
  40. A Signed-Rank Test for Clustered Data
  41. Response to Lee et al.
  42. Robust estimation and testing of haplotype effects in case-control studies
  43. A Simple and Improved Correction for Population Stratification in Case-Control Studies
  44. Statistical Models for Haplotype Sharing in Case-Parent Trio Data
  45. Inference on haplotype/disease association using parent-affected-child data: the projection conditional on parental haplotypes method
  46. Association mapping via a class of haplotype-sharing statistics
  47. Simple methods for assessing haplotype-environment interactions in case-only and case-control studies
  48. Genetic Studies of a Cluster of Acute Lymphoblastic Leukemia Cases in Churchill County, Nevada
  49. Investigating Childhood Leukemia in Churchill County, Nevada
  50. Comment
  51. Improved association analyses of disease subtypes in case-parent triads
  52. Rank-Sum Tests for Clustered Data
  53. Cross-Sectional Study
  54. Genetic Association Analysis Using Data from Triads and Unrelated Subjects
  55. Genetic Analysis Workshop 14: microsatellite and single-nucleotide polymorphism marker loci for genome-wide scans
  56. Robust testing of haplotype/disease association
  57. Standardization and denoising algorithms for mass spectra to classify whole-organism bacterial specimens
  58. An empirical bayes adjustment to increase the sensitivity of detecting differentially expressed genes in microarray experiments
  59. Comparison of prospective and retrospective methods for haplotype inference in case-control studies
  60. How special is a 'special' interval: modeling departure from length-biased sampling in renewal processes
  61. Inference on Haplotype Effects in Case-Control Studies Using Unphased Genotype Data
  62. Random error and undercounting in birth defects surveillance data: Implications for inference
  63. Performance Characteristics of a New Less Sensitive HIV-1 Enzyme Immunoassay for Use in Estimating HIV Seroincidence
  64. HFE genotype and transferrin saturation in the United States
  65. Estimation of Stage Occupation Probabilities in Multistage Models
  66. Marginal Analyses of Clustered Data When Cluster Size Is Informative
  67. Informative Missingness in Genetic Association Studies: Case-Parent Designs
  68. Bootstrap calibration of TRANSMIT for informative missingness of parental genotype data
  69. Marginal Analyses of Multistage Data
  70. Estimation of Integrated Transition Hazards and Stage Occupation Probabilities for Non-Markov Systems Under Dependent Censoring
  71. HIV Seroincidence Among Patients at Clinics for Sexually Transmitted Diseases in Nine Cities in the United States
  72. HIV seroconverting donors delay their return: screening test implications
  73. Subtype-specific Transmission Probabilities for Human Immunodeficiency Virus Type 1 among Injecting Drug Users in Bangkok, Thailand
  74. Midrank unification of rank tests for exact, tied, and censored data
  75. Analysis of Dynamic Cohort Data
  76. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers
  77. Evaluation of a Sensitive/Less-Sensitive Testing Algorithm Using the 3A11-LS Assay for Detecting Recent HIV Seroconversion among Individuals with HIV-1 Subtype B or E Infection in Thailand
  78. Nonparametric Maximum Likelihood Estimation for Competing Risks Survival Data Subject to Interval Censoring and Truncation
  79. Accounting for Unmeasured Population Substructure in Case-Control Studies of Genetic Association Using a Novel Latent-Class Model
  80. Marginal estimation for multi-stage models: waiting time distributions and competing risks analyses
  81. Nonparametric Estimation for the Three-Stage Irreversible Illness-Death Model
  82. The S-U algorithm for missing data problems
  83. Conditional and Unconditional Categorical Regression Models with Missing Covariates
  84. Repeat Screening for HIV: When to Test and Why
  85. Estimating the Extent of Tracking in Interval-Censored Chain-Of-Events Data
  86. Validating Marker-Based Incidence Estimates in Repeatedly Screened Populations
  87. Detection of Early HIV Infection and Estimation of Incidence Using a Sensitive/Less-Sensitive Enzyme Immunoassay Testing Strategy at Anonymous Counseling and Testing Sites in San Francisco
  88. Hold everything! Holding policies for protecting plasma supplies
  89. Fitting Semi-Markov Models to Interval-Censored Data with Unknown Initiation Times
  90. Discrete-Time Nonparametric Estimation for Semi-Markov Models of Chain-of-Events Data Subject to Interval Censoring and Truncation
  91. Kaplan–Meier representation of competing risk estimates
  92. HIV Seroincidence and Risk Factors Among Patients Repeatedly Tested for HIV Attending Sexually Transmitted Disease Clinics in the United States, 1991 to 1996
  93. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis
  94. New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes
  95. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  96. Inference Based on Imputed Failure Times for the Proportional Hazards Model with Interval-Censored Data
  97. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
  98. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'lvoire
  99. Steady-state calculation of the risk of HIV infection from transfusion of screened blood from repeat donors
  100. Markov Chains With Measurement Error: Estimating the `True' Course of a Marker of the Progression of Human Immunodeficiency Virus Disease
  101. Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States
  102. Upper and Lower Bound Distributions that Give Simultaneous Confidence Intervals for Quantiles
  103. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors
  104. Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia
  105. Estimation of Incidence of HIV Infection Using Cross-Sectional Marker Surveys
  106. Direct oral questions to blood donors: the impact on screening for human immunodeficiency virus
  107. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group
  108. Probability of female-to-male transmission of HIV-1 in Thailand
  109. Conditional Regression Analysis of the Exposure-Disease Odds Ratio Using Known Probability-of-Exposure Values
  110. [Backcalculation of HIV Infection Rates]: Comment
  111. Inferences About Exposure-Disease Associations Using Probability-of-Exposure Information
  112. Inferences About Exposure-Disease Associations Using Probability-of- Exposure Information
  113. HIV Infection among Patients in U.S. Acute Care Hospitals
  114. Continued Fraction Representation for Expected Cell Counts of a 2 x 2 Table: A Rapid and Exact Method for Conditional Maximum Likelihood Estimation
  115. Sample size determination for pair-matched case-control studies where the goal is interval estimation of the odds ratio
  116. Critical phenomena in randomly stirred fluids: Correlation functions, equation of motion, and crossover behavior
  117. Critical phenomena in randomly stirred fluids
  118. Modification of nonequilibrium fluctuations by interaction with surfaces